Identification of the benzodiazepines as a new class of antileishmanial agent

…, GD Coxon, G Owusu-Dapaah, E McFarlane…

Index: Clark, Rachel L.; Carter, Katharine C.; Mullen, Alexander B.; Coxon, Geoffrey D.; Owusu-Dapaah, George; McFarlane, Emma; Duong Thi, M. Dao; Grant, M. Helen; Tettey, Justice N.A.; Mackay, Simon P. Bioorganic and Medicinal Chemistry Letters, 2007 , vol. 17, # 3 p. 624 - 627

Full Text: HTML

Citation Number: 40

Abstract

The continual increase in drug resistance; the lack of new chemotherapeutic agents; the toxicity of existing agents and the increasing morbidity with HIV co-infection mean the search for new antileishmanial agents has never been more urgent. We have identified the benzodiazepines as a structural class for antileishmanial hit optimisation, and demonstrated that their in vitro activity is comparable with the clinically used drug, sodium stibogluconate ...

Related Articles:

One pot conversion of azido arenes to N-arylacetamides and N-arylformamides: synthesis of 1, 4-benzodiazepine-2, 5-diones and fused [2, 1-b] quinazolinones

[Tetrahedron Letters, , vol. 45, # 44 p. 8187 - 8190]

Cycloalkyl [b][1, 4] benzodiazepinoindoles are agonists at the human 5-HT 2C receptor

[Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 10 p. 2603 - 2607]

Cycloalkyl [b][1, 4] benzodiazepinoindoles are agonists at the human 5-HT 2C receptor

[Bioorganic and Medicinal Chemistry Letters, , vol. 14, # 10 p. 2603 - 2607]

New Routes to 1, 4-benzodiazepin-2, 5-diones

[Tetrahedron, , vol. 50, # 30 p. 9051 - 9060]

More Articles...